This led to the hypothesis that activation-driven increases in p53 protein within CLL cells, such as found in vivo within germinal centers [60] and in vitro within human B cell cultures activated by division-eliciting T cell independent stimuli [32], might drive BCL2 repression during CLL cycling. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.